Author:
Tarle Marko,Kraljić Ivo,Kaštelan Maja
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Carter HB, Piantadosi M, Isaacs JT (1990) Clinical evidence for and implications fo the multistep development of prostate cancer. J Urol 143:742
2. De Jong FH, Schroeder FH, Lock MTWT, Debruyne FMJ, de Voogt HJ, Klijn JGM (1987) Effects of long term treatment with the LHRH-analogue Buserelin on the pituitary-testicular axis in men with prostatic carcinoma. In: Klijn JGM, Paridaens R, Foekens JA (eds) Hormonal manipulation of cancer peptides, growth factors and new (anti) steroidal agents. Raven Press, New York, p 195
3. Urologic oncology,1986
4. Kaštelan M, Kraljié I, Tarle M (1992) NK cell activity in treated prostate cancer patients as a sensitive probe for circulating tumor cells: hormone regulatory effects in vivo. Prostate 21:111
5. Lahat N, Alexander N, Levin DR, Moskowitz B (1989) The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate. Cancer Immunol Immunother 28:208
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献